SCHEMBL2403258

SCHEMBL2403258

CC(C)N1CCN(C(=O)[C@H]2CC[C@H](NS(=O)(=O)c3ccccc3Cl)CC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
CNR1 P21554 7/20 0.46
CCR8 P51685 2/20 0.46
HTR1A P08908 1/20 0.45
HTR7 P34969 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
HRH3 Q9Y5N1 4/20 0.42
DRD2 P14416 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
KCNH2 Q12809 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2405226 1.00 ALDH1A1 (0.53) ALDH1A1L3MBTL1CNR1CCR8HTR1A
SCHEMBL2403265 1.00 ALDH1A1 (0.53) ALDH1A1L3MBTL1CNR1CCR8HTR1A
SCHEMBL2401724 0.89 CCR8 (0.52) ALDH1A1CNR1CCR8HRH2HRH1
SCHEMBL2401720 0.89 CCR8 (0.52) ALDH1A1CNR1CCR8HRH2HRH1
SCHEMBL2402226 0.89 CNR1 (0.51) CNR1CCR8KMT2ADRD2ADRA1D
SCHEMBL2402231 0.89 CNR1 (0.51) CNR1CCR8KMT2ADRD2ADRA1D
SCHEMBL2405449 0.89 CNR1 (0.51) CNR1CCR8KMT2ADRD2ADRA1D
SCHEMBL2401730 0.88 DRD2 (0.48) ALDH1A1CCR8HRH2HRH1HRH3
SCHEMBL2401728 0.88 DRD2 (0.48) ALDH1A1CCR8HRH2HRH1HRH3
SCHEMBL2403253 0.85 ATM (0.53) ALDH1A1L3MBTL1CNR1CCR8HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US claimed
EP-1979322-B1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY HOFFMANN LA ROCHE (CH) 2010-09-01 EP claimed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US claimed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US claimed
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US disclosed
EP-1979322-B1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY HOFFMANN LA ROCHE (CH) 2010-09-01 EP disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
EP-1979322-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2008-10-15 EP disclosed
WO-2007082840-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 WO disclosed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 ALDH1A1 430/4885L3MBTL1 3656/4885CNR1 8/4885
US-20070173511-A1 Cyclohexyl sulfonamide derivatives HRH3, HRH4, HRH1 ALDH1A1 430/4885L3MBTL1 3656/4885CNR1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.